Regeneron Falls After Q1 Miss; Announces $3B Share Buybacks

Seeking Alpha50minutes ago

Beyfortus Real-World Evidence Published In The Lancet Shows 82% Reduction In Infant RSV Hospitalizations

New real-world evidence shows Beyfortus (nirsevimab) substantially reduced RSV lower respiratory tract disease and hospitalizations in infants during the 2023-2024 RSV season, versus no intervention1-

Benzinga15:12

European Equities Traded in the US as American Depositary Receipts Decline

European equities traded in the US as American depositary receipts fell Tuesday morning, down 0.5% to 1,373.3 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led by food

MT NewswiresApr 30 23:11

Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Gilead Sciences (GILD) and Sanofi (OtherSNYNF)

TipRanksApr 30 14:31

Press Release: Annual General Meeting of April 30, 2024

Annual General Meeting of April 30, 2024Approval of the financial statements for the fiscal year 2023Distribution of a cash dividend of €3.76 per share, with payment as of May 15, 2024Board compositio

SanofiApr 30 12:00

Deutsche Bank Reaffirms Their Sell Rating on Sanofi (SNYNF)

TipRanksApr 29 20:25